Hanmi Pharmaceutical Company Limited

This study is testing a new drug called HM11260C for adults with type 2 diabetes whose blood sugar is still too high despite taking two common medications (metformin and dapagliflozin). About 118 participants will be randomly assigned to receive either the new drug or a placebo (…

This study aims to compare how two similar drugs are processed by the body and check their safety. It will enroll 60 healthy adults who will take each drug once in a specific order. The main goal is to understand how the body absorbs and handles these two versions of a medication…